Table 1.
Immunosuppressive treatment of seven graft-versus-host disease (GVHD) patients undergoing extracorporeal photochemotherapy and enrolled in the study.
Patients | Sex | GVHD | Treatment | Number of ECP cycles performed when enrolled |
---|---|---|---|---|
1 | F | Chronic | Tacrolymus, mophetil mycophenolate | 3rd cycle |
2 | F | Acute | Prednisone, cyclosporine | 2nd cycle |
3 | M | Acute | Cyclosporine | 3rd cycle |
4 | F | Chronic | Prednisone | 2nd cycle |
5 | M | Acute | Prednisone | 2nd cycle |
6 | M | Chronic | Cyclosporine, prednisone | 7th cycle |
7 | M | Acute | Cyclosporine, prednisone | 2nd cycle |
ECP: extracorporeal photochemotherapy.